Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

HLS Therapeutics Inc T.HLS

Alternate Symbol(s):  HLTRF

HLS Therapeutics Inc. is a pharmaceutical company focused on the acquisition and commercialization of late-stage development, commercial stage promoted and established branded pharmaceutical products in the North American markets. It is engaged in addressing unmet needs in the treatment of psychiatric disorders and cardiovascular disease. It is also focused on products targeting the central nervous system and cardiovascular therapeutic areas. Its products include Clozaril, CSAN Pronto, MyCare Psychiatry and Vascepa. Its Clozaril is an atypical antipsychotic indicated for the management of symptoms of treatment-resistant schizophrenia for the Canadian and United States markets. CSAN Pronto is a capillary point-of-care medical device designed to enhance and simplify the mandatory safety blood monitoring process for patients that are prescribed Clozaril. The Vascepa (icosapent ethyl capsules) is a single-molecule prescription product in use to reduce the risk of cardiovascular events.


TSX:HLS - Post by User

Bullboard Posts
Post by Aspertheoldmanon Feb 15, 2012 11:45pm
383 Views
Post# 19541166

AM biggest shareholder

AM biggest shareholder

Michael Blair is the biggest shareholder with about 4.3 million shres. So far he hasn't sold any.

Second biggest is Scotia Merchant Capital Corp (a unit 100% owned by Bank of Nova Scotia. In the last months, they have sold regularly, in an orderly fashion, a few hundred thousands, indicating they don't sell because bad news are coming.

They are not ready to sell at any price. Yesterday they sold only 11,200 shres and today (feb 15th) they sold only 5,200. All at price over $2.61

The recent action of AM is normal behaviour for any stock that is up  170 % over a year ago

I bot a few thousands today. It is the biggest position of my portfolio along with Boralex (BLX-t)

 

To PAGODAS

Here is what you wrote last october  (4 months ago) when AM was $1.65

 " They are in a very precarious position in that they sell product to car manufacturers. If the market decline is predicting a recession in the US, car makers get taken out to the woodshed far worse than other industries. It would impact their business severely. The risk reward here just doesn't make sense even with the yield. Dividends can easily be cut or stopped.........................................  "

If I understand your investment strategy, Buy high and Sell low

Bullboard Posts